ESC 365 - Phospholamban cardiomyopathy: from in vitro disease modeling to therapy

Delegate Premium access

Phospholamban cardiomyopathy: from in vitro disease modeling to therapy

Session: Cardiomyopathies

Topic: VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE

Speaker: Mr F. Deiman (Groningen, NL)

Event: HFA Winter Research Meeting 2026

Seminar Presentation

Add to my library

About the speaker

Mr Frederik Ernst Deiman

University Medical Centre Groningen, Groningen (Netherlands (The))

1 presentation

0 follower

3 more presentations in this session

Genes drive all

Speaker: Professor S. Heymans (Maastricht, NL)

Hypercontractility-driven oxidative stress impairs energy recycling in hypertrophic cardiomyopathy

Speaker: Doctor V. Sequeira (Wuerzburg, DE)

Targeting cardiomyopathies at the molecular level: innovations in gene therapy and multiomic precision medicine

Speaker: Professor C. Maack (Wuerzburg, DE)

Access the full session

Cardiomyopathies

Speakers: Mr F. Deiman, Professor S. Heymans, Doctor V. Sequeira, Professor C. Maack

About the event

HFA Winter Research Meeting 2026

26 January - 28 January 2026

Seminar

ESC 365 is supported by

novartis

Explore sponsored resources